Eylem Eliacik

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Due to the high transplant related morbidity and mortality (TRM), relatively younger acute leukemia patients that have a good performance status and no comorbidity are eligible for myeloablative(More)